Debt-to-equity in % of Unity Biotechnology, Inc. from Q3 2018 to Q1 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Unity Biotechnology, Inc. quarterly Debt-to-equity history and change rate from Q3 2018 to Q1 2025.
  • Unity Biotechnology, Inc. Debt-to-equity for the quarter ending 31 Mar 2025 was 320 %, a 122% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Unity Biotechnology, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q1 2025 320 +176 +122% 31 Mar 2025
Q4 2024 206 +73.2 +55% 31 Dec 2024
Q3 2024 161 +31.2 +24% 30 Sep 2024
Q2 2024 148 +22.4 +17.9% 30 Jun 2024
Q1 2024 144 +19.4 +15.6% 31 Mar 2024
Q4 2023 133 +6.56 +5.18% 31 Dec 2023
Q3 2023 130 +6.82 +5.55% 30 Sep 2023
Q2 2023 125 +3.79 +3.12% 30 Jun 2023
Q1 2023 125 +11.1 +9.82% 31 Mar 2023
Q4 2022 127 +23.3 +22.6% 31 Dec 2022
Q3 2022 123 +25.3 +25.8% 30 Sep 2022
Q2 2022 121 +33.1 +37.4% 30 Jun 2022
Q1 2022 113 +40.8 +56.1% 31 Mar 2022
Q4 2021 103 +39.2 +61.2% 31 Dec 2021
Q3 2021 97.7 +49.1 +101% 30 Sep 2021
Q2 2021 88.4 +52.5 +147% 30 Jun 2021
Q1 2021 72.6 +43.3 +148% 31 Mar 2021
Q4 2020 64 +44.6 +230% 31 Dec 2020
Q3 2020 48.6 +32.4 +200% 30 Sep 2020
Q2 2020 35.8 +23.3 +185% 30 Jun 2020
Q1 2020 29.3 +20 +215% 31 Mar 2020
Q4 2019 19.4 +4.96 +34.3% 31 Dec 2019
Q3 2019 16.2 -11.6 -41.7% 30 Sep 2019
Q2 2019 12.6 30 Jun 2019
Q1 2019 9.31 31 Mar 2019
Q4 2018 14.5 31 Dec 2018
Q3 2018 27.8 30 Sep 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.